145 related articles for article (PubMed ID: 21885611)
41. Acarbose is an effective treatment for severe hypertriglyceridemia secondary to l-asparaginase and dexamethasone.
Tan M; Wai D; Chng CL; Hwang W
Leuk Lymphoma; 2012 Jun; 53(6):1245-6. PubMed ID: 22149169
[No Abstract] [Full Text] [Related]
42. Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.
Tulstrup M; Larsen HB; Castor A; Rossel P; Grell K; Heyman M; Abrahamsson J; Söderhäll S; Åsberg A; Jonsson OG; Vettenranta K; Frandsen TL; Albertsen BK; Schmiegelow K;
Pediatr Blood Cancer; 2016 May; 63(5):865-71. PubMed ID: 26717887
[TBL] [Abstract][Full Text] [Related]
43. A
Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
[TBL] [Abstract][Full Text] [Related]
44. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.
Dupuis LL; Lu X; Mitchell HR; Sung L; Devidas M; Mattano LA; Carroll WL; Winick N; Hunger SP; Maloney KW; Kadan-Lottick NS
Cancer; 2016 Apr; 122(7):1116-25. PubMed ID: 26773735
[TBL] [Abstract][Full Text] [Related]
45. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
Nowak-Göttl U; Ahlke E; Fleischhack G; Schwabe D; Schobess R; Schumann C; Junker R
Blood; 2003 Apr; 101(7):2529-33. PubMed ID: 12517808
[TBL] [Abstract][Full Text] [Related]
46. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
47. Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia.
Pound CM; Keene DL; Udjus K; Humphreys P; Johnston DL
J Pediatr Hematol Oncol; 2007 Mar; 29(3):183-6. PubMed ID: 17356399
[TBL] [Abstract][Full Text] [Related]
48. [Comparison of polyethylene glycol conjugated asparaginase and L-asparaginase for treatment of childhood acute lymphoblastic leukemia].
Cooperation Group of Phase II Clinical Trial of PEG-Asp
Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):29-33. PubMed ID: 18512312
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
[No Abstract] [Full Text] [Related]
50. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.
Albertsen BK; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Heyman M; Schmiegelow K
J Clin Oncol; 2019 Jul; 37(19):1638-1646. PubMed ID: 30978155
[TBL] [Abstract][Full Text] [Related]
51. Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.
Labar B; Suciu S; Willemze R; Muus P; Marie JP; Fillet G; Berneman Z; Jaksic B; Feremans W; Bron D; Sinnige H; Mistrik M; Vreugdenhil G; De Bock R; Nemet D; Gilotay C; Amadori S; de Witte T;
Haematologica; 2010 Sep; 95(9):1489-95. PubMed ID: 20378563
[TBL] [Abstract][Full Text] [Related]
52. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.
Patel B; Richards SM; Rowe JM; Goldstone AH; Fielding AK
Leukemia; 2008 Feb; 22(2):308-12. PubMed ID: 17989709
[TBL] [Abstract][Full Text] [Related]
53. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.
Waber DP; Carpentieri SC; Klar N; Silverman LB; Schwenn M; Hurwitz CA; Mullenix PJ; Tarbell NJ; Sallan SE
J Pediatr Hematol Oncol; 2000; 22(3):206-13. PubMed ID: 10864051
[TBL] [Abstract][Full Text] [Related]
54. Pharmacology of PEG-asparaginase in childhood acute lymphoblastic leukemia (ALL).
Pinheiro JP; Lanvers C; Würthwein G; Boos J
Blood; 2002 Sep; 100(5):1923-4; author reply 1924-5. PubMed ID: 12211194
[No Abstract] [Full Text] [Related]
55. Is a New Protocol for Acute Lymphoblastic Leukemia Research or Standard Therapy?
Dekking SA; van der Graaf R; de Vries MC; Bierings MB; van Delden JJ; Kodish E; Lantos JD
Pediatrics; 2015 Sep; 136(3):566-70. PubMed ID: 26283776
[TBL] [Abstract][Full Text] [Related]
56. Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl Cysteine.
Sahoo RK; Sharma A
Pediatr Blood Cancer; 2011 Oct; 57(4):700. PubMed ID: 21656901
[No Abstract] [Full Text] [Related]
57. Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on Co-ALL-07-03 trial: a single centre analysis.
Kuhlen M; Moldovan A; Krull K; Meisel R; Borkhardt A
Klin Padiatr; 2014 May; 226(3):154-60. PubMed ID: 24710762
[TBL] [Abstract][Full Text] [Related]
58. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
Kurtzberg J; Asselin B; Bernstein M; Buchanan GR; Pollock BH; Camitta BM
J Pediatr Hematol Oncol; 2011 Dec; 33(8):610-6. PubMed ID: 22042277
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic paracentesis in an acute lymphoblastic leukemia child without characteristic symptoms of pancreatitis.
Chao YH; Sheu JN; Chen SM; Wu KH
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e47. PubMed ID: 22858569
[No Abstract] [Full Text] [Related]
60. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.
Bertaina A; Vinti L; Strocchio L; Gaspari S; Caruso R; Algeri M; Coletti V; Gurnari C; Romano M; Cefalo MG; Girardi K; Trevisan V; Bertaina V; Merli P; Locatelli F
Br J Haematol; 2017 Feb; 176(4):629-636. PubMed ID: 28116786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
